Recently discovered T cell subsets cannot keep their commitments

Journal of the American Society of Nephrology

Volumn 20, Issue 8, 2009, Pages 1677-1680

  Strom, Terry B ^a,b   Koulmanda, Maria ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; CD28 ANTIGEN;

CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; DIABETES MELLITUS; INFLAMMATION; INSULITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 68049146006     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008101027     Document Type: Short Survey

References (22)

1. O'Garra A, Arai N: The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10: 542-550, 2000 (Pubitemid 30831454)
2. Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, Oukka M, Kuchroo VK: IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487, 2007 (Pubitemid 47123515)
3. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170: 2081-2095, 1989
4. Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG: IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160: 2059-2064, 1998 (Pubitemid 28119882)
5. Steiger J, Nickerson PW, Steurer W, Moscovitch- Lopatin M, Strom TB: IL-2 knockout recipient mice reject islet cell allografts. J Immunol 155: 489-498, 1995
6. Li XC, Zand MS, Li Y, Zheng XX, Strom TB: On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J Immunol 161: 2241-2247, 1998 (Pubitemid 28397035)
7. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell 133: 775-787, 2008
8. Tang Q, Bluestone JA: The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 9: 239-244, 2008 (Pubitemid 351267321)
9. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4: 330-336, 2003
10. Allan SE, Broady R, Gregori S, Himmel ME, Locke N, Roncarolo MG, Bacchetta R, Levings MK: CD4+ T-regulatory cells: toward therapy for human diseases. Immunol Rev 223: 391-421, 2008 (Pubitemid 351986179)
11. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC: Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265, 2007 (Pubitemid 46919862)
12. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006
13. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F: Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8: 942-949, 2007 (Pubitemid 47300008)
14. Korn T, Oukka M, Kuchroo V, Bettelli E: Th17 cells: Effector T cells with inflammatory properties. Semin Immunol 19: 362-371, 2007 (Pubitemid 351274046)
15. Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL: A dominant function for interleukin 27 in generating interleukin 10- producing anti-inflammatory T cells. Nat Immunol 8: 1380-1389, 2007 (Pubitemid 350131175)
16. Manel N, Unutmaz D, Littman DR: The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9: 641-649, 2008 (Pubitemid 351714729)
17. Dong C: Diversification of T-helper-cell lineages: Finding the family root of IL-17-producing cells. Nat Rev Immunol 6: 329-333, 2006
18. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, Ernst M, Saris CJ, O'Shea JJ, Hunter CA: Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 8: 1363-1371, 2007 (Pubitemid 350131173)
19. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR: IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8: 967-974, 2007 (Pubitemid 47300011)
20. Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupe P, Barillot E, Soumelis V: A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9: 650-657, 2008 (Pubitemid 351712635)
21. Degauque N, Mariat C, Kenny J, Zhang D, Gao W, Vu MD, Alexopoulos S, Oukka M, Umetsu DT, DeKruyff RH, Kuchroo V, Zheng XX, Strom TB: Immunostimulatory Tim-1- specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 118: 735-741, 2008 (Pubitemid 351206561)
22. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, Shi H, Bonner-Weir S, Putheti P, Degauque N, Libermann TA, Auchincloss H Jr, Flier JS, Strom TB: Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci USA 105: 16242-16247, 2008